SRx Health Solutions (SRXH) Depreciation & Amortization (CF) (2016 - 2025)
SRx Health Solutions' Depreciation & Amortization (CF) history spans 14 years, with the latest figure at $802000.0 for Q2 2025.
- For Q2 2025, Depreciation & Amortization (CF) fell 32.38% year-over-year to $802000.0; the TTM value through Sep 2025 reached $1.7 million, up 4.8%, while the annual FY2025 figure was $100000.0, N/A changed from the prior year.
- Depreciation & Amortization (CF) reached $802000.0 in Q2 2025 per SRXH's latest filing, up from $26000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.2 million in Q2 2024 to a low of $26000.0 in Q1 2025.
- Average Depreciation & Amortization (CF) over 5 years is $446222.2, with a median of $419000.0 recorded in 2023.
- The largest YoY upside for Depreciation & Amortization (CF) was 181.71% in 2024 against a maximum downside of 92.57% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $409000.0 in 2021, then increased by 3.91% to $425000.0 in 2022, then dropped by 2.12% to $416000.0 in 2023, then surged by 121.15% to $920000.0 in 2024, then fell by 12.83% to $802000.0 in 2025.
- Per Business Quant, the three most recent readings for SRXH's Depreciation & Amortization (CF) are $802000.0 (Q2 2025), $26000.0 (Q1 2025), and $920000.0 (Q4 2024).